Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease

Seong Mi Moon, Byung Woo Jhun, Sun Young Baek, Seonwoo Kim, Kyeongman Jeon, Ryoung Eun Ko, Sun Hye Shin, Hyun Lee, O. Jung Kwon, Hee Jae Huh, Chang Seok Ki, Nam Yong Lee, Myung Jin Chung, Kyung Soo Lee, Sung Jae Shin, Charles L. Daley, Won Jung Koh

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Information about the natural history of nontuberculous mycobacterial pulmonary disease (NTM-PD) is limited. The purpose of this study was to evaluate the long-term natural history of non-cavitary nodular bronchiectatic NTM-PD and the factors associated with treatment initiation and the frequency of spontaneous sputum culture conversion after diagnosis of NTM-PD. Methods: We evaluated 1,021 patients with newly diagnosed non-cavitary nodular bronchiectatic NTM-PD caused by Mycobacterium avium complex or M. abscessus between 2003 and 2013. Results: Of 1,021 patients, 562 (55%) initiated antibiotic treatment and 459 (45%) did not. Young age (adjusted hazard ratio [aHR] = 0.99; 95% confidence interval [CI] = 0.98–0.99), low body mass index (aHR = 0.96; 95% CI = 0.93–0.99), previous history of tuberculosis (aHR = 1.23; 95% CI = 1.01–1.50), respiratory complaints such as cough (aHR = 1.36; 95% CI = 1.05–1.75) and sputum production (aHR = 1.47; 95% CI = 1.13–1.91), and high number of involved lobes on high-resolution computed tomography (aHR = 1.22; 95% CI = 1.14–1.31) were associated with treatment initiation. Of 459 patients who did not initiate treatment, 157 (34%) showed spontaneous sputum culture conversion. None of the clinical factors was associated with spontaneous conversion. After spontaneous culture conversion, 26 of 157 (17%) showed redeveloped NTM-PD caused by a species different from the original species. Conclusions: The natural history of non-cavitary nodular bronchiectatic NTM-PD is variable. After diagnosis, the decision to initiate antibiotic therapy should be individualized based on consideration of the risk factors for disease progression. However, for patients who do not start antibiotic therapy, continuous and lifetime follow-up is recommended to manage underlying bronchiectasis and the possibility of late progression of NTM-PD.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalRespiratory Medicine
Volume151
DOIs
Publication statusPublished - 2019 May

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease'. Together they form a unique fingerprint.

  • Cite this

    Moon, S. M., Jhun, B. W., Baek, S. Y., Kim, S., Jeon, K., Ko, R. E., Shin, S. H., Lee, H., Kwon, O. J., Huh, H. J., Ki, C. S., Lee, N. Y., Chung, M. J., Lee, K. S., Shin, S. J., Daley, C. L., & Koh, W. J. (2019). Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease. Respiratory Medicine, 151, 1-7. https://doi.org/10.1016/j.rmed.2019.03.014